Evaluation of Testing of Acute Leukemia Samples: Survey Result From the College of American Pathologists

Tracy I George, Joseph A Tworek, Nicole E Thomas

  • 1From the Department of Pathology, University of New Mexico, Albuquerque (Dr George); the Department of Pathology, St. Joseph Mercy Hospital, Ann Arbor, Michigan (Dr Tworek); Laboratory and Pathology Quality Center (Mses Thomas and Fatheree) and Statistics Department (Ms Souers), College of American Pathologists, Northfield, Illinois; Department of Laboratory Medicine and Pathology, Mayo Clinic Florida, Jacksonville (Dr Nakhleh); and Department of Pathology, Stanford University, Stanford, California (Dr Arber).

Insights

Physicians routinely use flow cytometry and karyotyping for acute leukemia (AL) diagnosis. However, significant variations exist in other genetic, immunohistochemistry, and cytochemistry testing practices.

Area of Science:

  • Hematology
  • Oncology
  • Clinical Pathology

Background:

  • Acute leukemia (AL) classification and prognosis are complex.
  • Current diagnostic testing practices for AL are not well-defined.

Purpose of the Study:

  • To survey physicians on their current test ordering practices for acute leukemia diagnosis.
  • To establish a baseline understanding of AL diagnostic testing prior to guideline development.

Main Methods:

  • A survey was designed by an expert panel from the College of American Pathologists (CAP).
  • Members of professional hematology societies were asked to describe their AL diagnostic test ordering practices.
  • Two hundred ninety-four responses were received and analyzed.

Main Results:

  • Flow cytometry and karyotype analysis are routinely performed for both acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).
  • Fluorescence in situ hybridization (FISH) studies are also commonly used.
  • Significant variation exists in the utilization of other molecular studies, immunohistochemistry, and cytochemistry.

Conclusions:

  • Flow cytometry and karyotyping are standard diagnostic tests for acute leukemia.
  • There is considerable heterogeneity in the application of other genetic and specialized testing modalities in AL diagnosis.
  • Further standardization of AL diagnostic testing may be warranted.
Abstract

Related Concept Videos